Cargando…
Sarcopenia in cancer: Risking more than muscle loss
Sarcopenia is characterised by progressive and extensive skeletal muscle degeneration and is associated with functional decline. Sarcopenia has primary and secondary aetiology, arising as a result of the ageing process or through chronic cytokine-mediated inflammation (associated with health conditi...
Autores principales: | Anjanappa, Milan, Corden, Michael, Green, Andrew, Roberts, Darren, Hoskin, Peter, McWilliam, Alan, Choudhury, Ananya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769854/ https://www.ncbi.nlm.nih.gov/pubmed/33385074 http://dx.doi.org/10.1016/j.tipsro.2020.10.001 |
Ejemplares similares
-
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
por: Shortall, Jane, et al.
Publicado: (2023) -
Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021) -
Ezrin, more than a metastatic detERMinant?
por: Hoskin, Victoria, et al.
Publicado: (2019) -
Is muscle failure a better term than sarcopenia?
por: Suetta, Charlotte, et al.
Publicado: (2019) -
Editor’s choice: sarcopenia or loss of muscle mass
por: Walker, Richard F
Publicado: (2012)